(0.08%) 5 521.25 points
(0.12%) 39 890 points
(0.19%) 19 788 points
(0.00%) $81.63
(0.43%) $2.82
(-0.32%) $2 336.90
(0.02%) $29.53
(0.27%) $1 004.50
(0.03%) $0.932
(0.03%) $10.54
(0.02%) $0.788
(-2.06%) $86.18
6.87% $ 4.20
Live Chart Being Loaded With Signals
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways...
Stats | |
---|---|
Dzisiejszy wolumen | 414 897 |
Średni wolumen | 594 638 |
Kapitalizacja rynkowa | 134.04M |
EPS | $-0.230 ( Q1 | 2024-05-15 ) |
Następna data zysków | ( $-0.340 ) 2024-08-19 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-4.83 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00700 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-05 | Walbert Timothy P | Buy | 9 279 | Stock Option (Right to Buy) |
2024-06-05 | Seidenberg Beth C | Buy | 51 459 | Stock Option (Right to Buy) |
2024-06-05 | Parsey Merdad | Buy | 51 459 | Stock Option (Right to Buy) |
2024-06-05 | Hoelscher Paul W. | Buy | 9 279 | Stock Option (Right to Buy) |
2024-06-05 | Grammer Elizabeth A | Buy | 51 459 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-96.24 |
Last 39 transactions |
Buy: 5 086 661 | Sell: 305 517 947 |
Wolumen Korelacja
Sagimet Biosciences Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sagimet Biosciences Inc. Korelacja - Waluta/Towar
Sagimet Biosciences Inc. Finanse
Annual | 2023 |
Przychody: | $2.00M |
Zysk brutto: | $2.00M (100.00 %) |
EPS: | $-1.180 |
FY | 2023 |
Przychody: | $2.00M |
Zysk brutto: | $2.00M (100.00 %) |
EPS: | $-1.180 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-1.380 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej